Drug Approval | May 04, 2023
Indoco receives EIR for its Plant I manufacturing facility in Goa
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Apollo continues to invest in genomics technology and research for better patient care
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Subscribe To Our Newsletter & Stay Updated
